GZMB and Miyoshi myopathy: Given the reduction in DNAM-1 in the ILC2s of MM patients, we investigated their expression of GZMB and, interestingly, we found that the ILC2s of the PB but not BM expressed a considerable level of this cytotoxic molecule (Figure 2C).